Vasa Therapeutics
Vasa Therapeutics is a preclinical-stage biopharmaceutical company focused on developing novel therapies for cardiovascular aging. Their lead candidate, VS-041, targets heart failure with preserved ejection fraction (HFpEF) and is entering the final stages of preclinical development. The company aims to extend healthy lifespan through personalized medicine-based treatments.
Buy Funded Startups lists
Funding Round: Seed
Funding Amount: $6M
Date: 03-Jan-2024
Investors: Orphinic Scientific SA, NuFund Venture Group, SeedFolio
Markets: Biotechnology, Cardiovascular Disease, Personalized Medicine, Drug discovery, Aging, Heart Failure with preserved Ejection Fraction, Sarcopenia, Obesity, Chronic Kidney Disease, Peripheral Artery Disease, Arrhythmia, and Longevity
HQ: Encinitas, California, United States
Founded: 2019
Website: https://www.vasatherapeutics.com
LinkedIn: https://www.linkedin.com/company/vasa-therapeutics
Crunchbase: https://www.crunchbase.com/organization/vasa-therapeutics
Leave a Comment
Comments
No comments yet.